Low-dose-rate iodine-125 seed air kerma strength measurement intercomparison

被引:0
|
作者
Poder, Joel [1 ,2 ]
Smith, Ryan [3 ]
Haworth, Annette [4 ]
机构
[1] St George Hosp, Canc Care Ctr, Kogarah, NSW 2217, Australia
[2] Univ Wollongong, Ctr Med Radiat Phys, Wollongong, NSW, Australia
[3] Alfred Hosp, Alfred Hlth Radiat Oncol, Melbourne, Vic, Australia
[4] Univ Sydney, Sch Phys, Camperdown, NSW, Australia
关键词
I-125; Brachytherapy; Air kerma strength; Calibration; Intercomparison; EMITTING BRACHYTHERAPY SOURCES; RADIATION-THERAPY; RANDOMIZED-TRIAL; CALIBRATION; RECOMMENDATIONS; CHAMBER;
D O I
10.1016/j.brachy.2019.10.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PURPOSE: The purpose of this study was to investigate the rate of compliance of air kerma strength (AKS) measurements of iodine-125 (1-125) seeds with international recommendations by departments in Australia and determine the potential impact of noncompliance. METHODS AND MATERIALS: To achieve this aim, we present an intercomparison of AKS measurements for a single I-125 seed performed by 11 radiotherapy departments in Australia. Measurements were performed at two sites, with each participating department traveling to one of the two host sites and measuring the AKS using their own equipment and local protocols. Each of the AKS measurements was compared with each other and the manufacturer-certified AKS. RESULTS: Nine of the 11 participating departments measured AKS fell within +/- 3% of the manufacturer's calibration certificate value, whereas all participating departments measured AKS within +/- 5% of the manufacturer's calibration certificate value. The total spread of the measured AKS among the 11 departments was 7.7%. Only two of the 11 participating departments complied with international recommendations and had their well chamber calibrated within the last 2 years. In addition, 2 of the 11 departments used a well chamber calibrated that was calibrated with a different seed model used during the intercomparison, whereas 4 of the 11 departments calibrated their well chamber "in-house" using a factory-calibrated seed provided by the seed manufacturer. CONCLUSIONS: A significant variation in the methods used and frequency of calibration of well chambers were observed among the participating departments. The results of this study support the international recommendations on frequency and methodology of well chamber calibration. Failure to follow these recommendations significantly increases the uncertainty in AKS measurement of I-125 seeds. Crown Copyright (C) 2020 Published by Elsevier Inc. on behalf of American Brachytherapy Society. All rights reserved.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 50 条
  • [21] CHANGES WITH TIME IN PROGNOSTIC FACTORS IN LOCALIZED PROSTATE CANCER SURVIVORS AFTER LOW-DOSE-RATE PERMANENT SEED IMPLANT BRACHYTHERAPY WITH IODINE-125; CONDITIONAL SURVIVAL ANALYSIS
    Hasegawa, Masanori
    Saito, Shiro
    Yorozu, Atsunori
    Tetsuo, Monma
    Nishiyama, Toru
    Yagi, Yasuto
    Shigeta, Keisuke
    Shoji, Sunao
    Miyajima, Akira
    JOURNAL OF UROLOGY, 2022, 207 (05): : E252 - E253
  • [22] A machine-learning approach based on 409 treatments to predict optimal number of iodine-125 seeds in low-dose-rate prostate
    Boussion, Nicolas
    Schick, Ulrike
    Dissaux, Gurvan
    Ollivier, Luc
    Goasduff, Gaelle
    Pradier, Olivier
    Valeri, Antoine
    Visvikis, Dimitris
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2021, 13 (05) : 541 - 548
  • [23] LOW-DOSE-RATE IODINE-125 SEEDS BRACHYTHERAPY: PSA NADIR LESS THAN 1 NG/ML AS PROGNOSTIC FACTOR.
    Reis, Leonardo O.
    Monti, C. R.
    Castilho, Lisias N.
    Gialluca, V. D.
    Reinato, Jose A. S.
    Uhmann, E.
    Kawakami, N. S.
    Ferreira, Ubirajara
    JOURNAL OF UROLOGY, 2010, 183 (04): : E792 - E793
  • [24] RESPONSE OF NORMAL AND MALIGNATN TISSUE IRRADIATED AT LOW DOSE RATE WITH PERMANENT IODINE-125 IMPLANTS
    SONDHAUS, C
    SCALLON, J
    SNYDER, S
    STEPHENS, S
    RADIATION RESEARCH, 1967, 31 (03) : 572 - &
  • [25] Variation regarding the calibration certificate and uncertainties in the calibration of air-kerma strength reference (AKSR) of Amersham 6711 Iodine-125 seeds
    Luna, V
    Gonzalez, JM
    Fernandez, J
    Crelgo, D
    Rodriguez, A
    Sanchez, P
    Vivanco, J
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S102 - S102
  • [26] PSA bounce and biochemical failure analysis in low dose rate iodine-125 prostate brachytherapy boost
    Bulto Boque, N.
    Goni Ramirez, A.
    de Paula Carranza, B.
    Saenz de Urturi Albisu, E. M.
    Pagola Divasson, M.
    Ortiz de Urbina Ugarte, D. I.
    Rosa Nieto, J.
    Ayete Andreu, A.
    Erzilbengoa Izaguirre, M.
    Pastor Sanchis, V.
    Bartres Salido, A.
    Suarez Alvarez, N.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1135 - S1136
  • [27] Particle Swarm Optimization in Radial Dose Function Fitting for a Novel Iodine-125 Seed
    Wu, X.
    Duan, J.
    Popple, R.
    Cardan, R.
    Huang, M.
    Benhabib, S.
    Shen, S.
    Brezovich, I.
    MEDICAL PHYSICS, 2014, 41 (06) : 283 - 283
  • [28] Preliminary Study on Extrapolation Ionization Chamber for Measurement Air Kerma Strength of Domestic 6711 125I Seed
    Liu C.
    Li D.
    Wang H.
    Zhang J.
    Hang Z.
    Huang J.
    Ni N.
    Gao H.
    Liu Y.
    Song M.
    Yuanzineng Kexue Jishu/Atomic Energy Science and Technology, 2022, 56 (10): : 2195 - 2202
  • [29] New 125I and 103Pd brachytherapy seed air-kerma-strength measurement techniques
    Culberson, WS
    Selbach, HJ
    Kramer, HM
    DeWerd, LA
    MEDICAL PHYSICS, 2004, 31 (06) : 1713 - 1713
  • [30] An EGSnrc investigation of the air-kerma strength, dose rate constant, and radial dose function of 125I brachytherapy sources
    Sahoo S.
    Palani Selvam T.
    Radiological Physics and Technology, 2009, 2 (2) : 198 - 204